Vyome Holdings, Inc. Common Stock
Veridion Score
Composite trend over time
Why is HIND moving today?
Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for HIND.
HIND insider activity
Vyome Holdings, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for HIND.
HIND contract awards, year to date.
Public federal awards linked to this ticker.
HIND lobbying filings, year to date.
Registered lobbying filings matched to Vyome Holdings, Inc. Common Stock.